Prothrombin deficiency caused by compound heterozygosity for two novel mutations in the prothrombin gene associated with a bleeding tendency

Thrombosis and Haemostasis

Volumn 95, Issue 1, 2006, Pages 195-198

  Stanchev, Hristo ^a   Philips, Malou ^b   Villoutreix, Bruno O ^c   Aksglæde, Lise ^a   Lethagen, Stefan ^d,e   Thorsen, Sixtus ^b  

^a Section of Endocrinology   (Denmark)

^b Rigshospitalet   (Denmark)

^c INSERM   (France)

^d Mental Health Services CPH   (Denmark)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; PROTHROM-PLEX; PROTHROMBIN;

ANEMIA; ARTICLE; BLEEDING TENDENCY; CASE REPORT; CLINICAL FEATURE; DIODE LASER; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; EPISTAXIS; ERYTHROCYTE TRANSFUSION; FETOMATERNAL TRANSFUSION; GENE MUTATION; GENOTYPE; HEMOGLOBIN BLOOD LEVEL; HETEROZYGOSITY; HUMAN; METABOLIC ACIDOSIS; NEWBORN; NONSENSE MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEIC ACID BASE SUBSTITUTION; PHENOTYPE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTHROMBIN DEFICIENCY; RESPIRATORY DISTRESS; RETROLENTAL FIBROPLASIA;

EID: 33645541660     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1612584     Document Type: Article

References (26)

1. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004; 104: 1243-52.
2. International Society on Thrombosis and Haemostasis. Mutations of patients with prothrombin deficiency. http://www.med.unc.edu/isth/mutations-databases/prothrombin.htm. 2004.
3. Knudsen TT, Thorsen S, Jensen SA et al. Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects. Gut 2005; 54: 515-21.
4. Laurell CB. Electroimmuno assay. Scand J Clin Lab Invest Suppl 1972; 124: 21-37.
5. Dziegiel MH, Koldkjær O, Berkowicz A. Massive antenatal fetomaternal hemorrhage: evidence for long-term survival of fetal red blood cells. Transfusion 2005; 45: 539-14.
6. Fledelius HC Retinal haemorrhages in premature infants: a pathogenetic alternative diagnosis to child abuse. Acta Ophthalmol Scand 2005; 83: 424-7.
7. Maquat LE Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nat Rev Mol Cell Biol 2004; 5: 89-99.
8. S. Kostova Z, Wolf DH. For whom the bell tolls: protein quality control of the endoplasmic reticulum and the ubiquitin-proteasome connection. EMBO J 2003; 22: 2309-17.
9. Inacio A, Silva AL, Pinto J et al. Nonsense mutations in close proximity to the initiation codon fail to trigger full nonsense-mediated mRNA decay. J Biol Chem 2004; 279: 32170-80.
10. Banfield DK, MacGillivray RT. Partial characterization of vertebrate prothrombin cDNAs: amplification and sequence analysis of the B chain of thrombin from nine different species. Proc Natl Acad Sci USA 1992; 89: 2779-83.
11. Pineda AO, Carrell CJ, Bush LA et al. Molecular dissection of Na+ binding to thrombin. J Biol Chem 2004; 279: 31842-53.
12. Bode W, Turk D, Karshikov A. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloro-methylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships. Protein Sci 1992; 1: 426-71.
13. Vijayalakshmi J, Padmanabhan KP, Mann KG et al. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin. Protein Sci 1994; 3: 2254-71.
14. Degen SJ, McDowell SA, Sparks LM et al. Prothrombin Frankfurt: a dysfunctional prothrombin characterized by substitution of Glu-466 by Ala. Thromb Haemost 1995; 73: 203-9.
15. Sun WY, Smirnow D, Jenkins ML et al. Prothrombin Scranton: substitution of an amino acid residue involved in the binding of Na+ (LYS-556 to THR) leads to dysprothrombinemia. Thromb Haemost 2001; 85: 651-4.
16. Henriksen RA, Dunham CK, Miller LD et al. Prothrombin Greenville, Arg517-->Gln, identified in an individual heterozygous for dysprothrombinemia. Blood 1998; 91: 2026-31.
17. Miyata T, Aruga R, Umeyama H et al. Prothrombin Salakta: substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activity. Biochemistry 1992; 31: 7457-62.
18. Akhavan S, De Cristofaro R, Peyvandi F et al. Molecular and functional characterization of a natural homozygous Arg67His mutation in the prothrombin gene of a patient with a severe procoagulant defect contrasting with a mild hemorrhagic phenotype. Blood 2002; 100: 1347-53.
19. Di Cera E Thrombin interactions. Chest 2003; 124: 11S-7S.
20. Sun WY, Witte DP, Degen JL et al. Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc Natl Acad Sci USA 1998; 95: 7597-602.
21. Xue J, Wu Q, Westfield LA et al. Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice. Proc Natl Acad Sci USA 1998; 95: 7603-7.
22. Giacoia GP Severe fetomaternal hemorrhage: a review. Obstet Gynecol Surv 1997; 52: 372-80.
23. Fledelius HC, Gote H, Greisen G et al. Surveillance for retinopathy of prematurity in a Copenhagen high-risk sample 1999-2001. Has progress reached a plateau? Acta Ophthalmol Scand 2004; 82: 32-7.
24. Chiang MF, Arons RR, Flynn JT et al. Incidence of retinopathy of prematurity from 1996 to 2000: analysis of a comprehensive New York state patient database. Ophthalmology 2004; 111: 1317-25.
25. Rodriguez RJ. Management of respiratory distress syndrome: an update. Respir Care 2003; 48: 279-86.
26. Whitelaw A. Intraventricular haemorrhage and posthaemorrhagic hydrocephalus: pathogenesis, prevention and future interventions. Semin Neonatol 2001; 6: 135-46.